Intratumor genetic heterogeneity in squamous cell carcinoma of the oral cavity
dc.contributor.author | Zandberg, Dan P. | |
dc.contributor.author | Tallon, Luke J. | |
dc.contributor.author | Nagaraj, Sushma | |
dc.contributor.author | Sadzewicz, Lisa K. | |
dc.contributor.author | Zhang, Yuji | |
dc.contributor.author | Strome, Maxwell B. | |
dc.contributor.author | Zhao, Xuechu E. | |
dc.contributor.author | Vavikolanu, Kranthi | |
dc.contributor.author | Zhang, Xiaoyu | |
dc.contributor.author | Papadimitriou, John C. | |
dc.contributor.author | Hubbard, Fleesie A. | |
dc.contributor.author | Bentzen, Søren M. | |
dc.contributor.author | Strome, Scott E. | |
dc.contributor.author | Fraser, Claire M. | |
dc.date.accessioned | 2019-08-09T17:14:06Z | |
dc.date.available | WITHHELD_13_MONTHS | |
dc.date.available | 2019-08-09T17:14:06Z | |
dc.date.issued | 2019-08 | |
dc.identifier.citation | Zandberg, Dan P.; Tallon, Luke J.; Nagaraj, Sushma; Sadzewicz, Lisa K.; Zhang, Yuji; Strome, Maxwell B.; Zhao, Xuechu E.; Vavikolanu, Kranthi; Zhang, Xiaoyu; Papadimitriou, John C.; Hubbard, Fleesie A.; Bentzen, Søren M. ; Strome, Scott E.; Fraser, Claire M. (2019). "Intratumor genetic heterogeneity in squamous cell carcinoma of the oral cavity." Head & Neck 41(8): 2514-2524. | |
dc.identifier.issn | 1043-3074 | |
dc.identifier.issn | 1097-0347 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/150549 | |
dc.description.abstract | BackgroundWe sought to evaluate intratumor heterogeneity in squamous cell carcinoma of the oral cavity (OCC) and specifically determine the effect of physical separation and histologic differentiation within the same tumor.MethodsWe performed whole exome sequencing on five biopsy sites—two from well‐differentiated, two from poorly differentiated regions, and one from normal parenchyma—from five primary OCC specimens.ResultsWe found high levels of intratumor heterogeneity and, in four primary tumors, identified only 0 to 2 identical mutations in all subsites. We found that the heterogeneity inversely correlated with physical separation and that pairs of well‐differentiated samples were more similar to each other than analogous poorly differentiated specimens. Only TP53 mutations, but not other purported “driver mutations” in head and neck squamous cell carcinoma, were found in multiple biopsy sites.ConclusionThese data highlight the challenges to characterization of the mutational landscape of OCC with single site biopsy and have implications for personalized medicine. | |
dc.publisher | John Wiley & Sons, Inc. | |
dc.subject.other | genetic | |
dc.subject.other | SCCHN | |
dc.subject.other | oral cavity | |
dc.subject.other | squamous cell carcinoma | |
dc.subject.other | heterogeneity | |
dc.title | Intratumor genetic heterogeneity in squamous cell carcinoma of the oral cavity | |
dc.type | Article | |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Otolaryngology | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.description.peerreviewed | Peer Reviewed | |
dc.description.bitstreamurl | https://deepblue.lib.umich.edu/bitstream/2027.42/150549/1/hed25719.pdf | |
dc.description.bitstreamurl | https://deepblue.lib.umich.edu/bitstream/2027.42/150549/2/hed25719_am.pdf | |
dc.identifier.doi | 10.1002/hed.25719 | |
dc.identifier.source | Head & Neck | |
dc.identifier.citedreference | Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high‐throughput sequencing data. Nucleic Acids Res. 2010; 38: e164. | |
dc.identifier.citedreference | Rizvi NA, Hellmann MD, Snyder A, et al. Cancer immunology. Mutational landscape determines sensitivity to PD‐1 blockade in non‐small cell lung cancer. Science. 2015; 348: 124 ‐ 128. | |
dc.identifier.citedreference | Le DT, Uram JN, Wang H, et al. PD‐1 blockade in tumors with mismatch‐repair deficiency. N Engl J Med. 2015; 372: 2509 ‐ 2520. | |
dc.identifier.citedreference | Le DT, Durham JN, Smith KN, et al. Mismatch repair deficiency predicts response of solid tumors to PD‐1 blockade. Science. 2017; 357: 409 ‐ 413. | |
dc.identifier.citedreference | McGranahan N, Furness AJ, Rosenthal R, et al. Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade. Science. 2016; 351: 1463 ‐ 1469. | |
dc.identifier.citedreference | Melief CJM, van Hall T, Arens R, Ossendorp F, van der Burg SH. Therapeutic cancer vaccines. J Clin Invest. 2015; 125: 3401 ‐ 3412. | |
dc.identifier.citedreference | Stransky N, Egloff AM, Tward AD, et al. The mutational landscape of head and neck squamous cell carcinoma. Science. 2011; 333: 1157 ‐ 1160. | |
dc.identifier.citedreference | Agrawal N, Frederick MJ, Pickering CR, et al. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science. 2011; 333: 1154 ‐ 1157. | |
dc.identifier.citedreference | The Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015; 517: 576 ‐ 582. | |
dc.identifier.citedreference | Yan LI, Zhan C, Wu J, Wang S. Expression profile analysis of head and neck squamous cell carcinomas using data from The Cancer Genome Atlas. Mol Med Rep. 2016; 13: 4259 ‐ 4265. | |
dc.identifier.citedreference | Gerlinger M, Rowan AJ, Horswell S, et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med. 2012; 366: 883 ‐ 892. | |
dc.identifier.citedreference | Yachida S, Jones S, Bozic I, et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature. 2010; 467: 1114 ‐ 1117. | |
dc.identifier.citedreference | de Bruin EC, McGranahan N, Mitter R, et al. Spatial and temporal diversity in genomic instability processes defines lung cancer evolution. Science. 2014; 346: 251 ‐ 256. | |
dc.identifier.citedreference | Jamal‐Hanjani M, Wilson GA, McGranahan N, et al. Tracking the evolution of non–small‐cell lung cancer. N Engl J Med. 2017; 376: 2109 ‐ 2121. | |
dc.identifier.citedreference | Zhang J, Fujimoto J, Zhang J, et al. Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing. Science. 2014; 346: 256 ‐ 259. | |
dc.identifier.citedreference | Favero F, Joshi T, Marquard AM, et al. Sequenza: allele‐specific copy number and mutation profiles from tumor sequencing data. Ann Oncol. 2015; 26: 64 ‐ 70. | |
dc.identifier.citedreference | Li H, Durbin R. Fast and accurate short read alignment with Burrows‐Wheeler transform. Bioinformatics. 2009; 25: 1754 ‐ 1760. | |
dc.identifier.citedreference | Li H, Handsaker B, Wysoker A, et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics. 2009; 25: 2078 ‐ 2079. | |
dc.identifier.citedreference | Van der Auwera GA, Carneiro MO, Hartl C, et al. From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline. Curr Protoc Bioinformatics. 2013; 43: 11 10 ‐ 11–33. | |
dc.identifier.citedreference | Cibulskis K, Lawrence MS, Carter SL, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotech. 2013; 31: 213 ‐ 219. | |
dc.identifier.citedreference | Koboldt DC, Zhang Q, Larson DE, et al. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res. 2012; 22: 568 ‐ 576. | |
dc.identifier.citedreference | Reva B, Antipin Y, Sander C. Predicting the functional impact of protein mutations: application to cancer genomics. Nucleic Acids Res. 2011; 39: e118. | |
dc.identifier.citedreference | Forbes SA, Beare D, Gunasekaran P, et al. COSMIC: exploring the world’s knowledge of somatic mutations in human cancer. Nucleic Acids Res. 2015; 43: D805 ‐ D811. | |
dc.identifier.citedreference | Lawrence MS, Stojanov P, Mermel CH, et al. Discovery and saturation analysis of cancer genes across 21 tumour types. Nature. 2014; 505: 495 ‐ 501. | |
dc.identifier.citedreference | Schwarzer G. meta: an R package for meta‐analysis. R News. 2007; 7: 40 ‐ 45. | |
dc.identifier.citedreference | Ledgerwood LG, Kumar D, Eterovic AK, et al. The degree of intratumor mutational heterogeneity varies by primary tumor sub‐site. Oncotarget. 2016; 7: 27185 ‐ 27198. | |
dc.identifier.citedreference | Zhang XC, Xu C, Mitchell RM, et al. Tumor evolution and intratumor heterogeneity of an oropharyngeal squamous cell carcinoma revealed by whole‐genome sequencing. Neoplasia. 2013; 15: 1371 ‐ 1378. | |
dc.identifier.citedreference | McGranahan N, Swanton C. Clonal heterogeneity and tumor evolution: past, present, and the future. Cell. 2017; 168: 613 ‐ 628. | |
dc.identifier.citedreference | Califano J, van der Riet P, Westra W, et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res. 1996; 56: 2488 ‐ 2492. | |
dc.identifier.citedreference | Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990; 61: 759 ‐ 767. | |
dc.identifier.citedreference | Nowell P. The clonal evolution of tumor cell populations. Science. 1976; 194: 23 ‐ 28. | |
dc.identifier.citedreference | Fisher R, Horswell S, Rowan A, et al. Development of synchronous VHL syndrome tumors reveals contingencies and constraints to tumor evolution. Genome Biol. 2014; 15: 433. | |
dc.identifier.citedreference | Campbell PJ, Yachida S, Mudie LJ, et al. The patterns and dynamics of genomic instability in metastatic pancreatic cancer. Nature. 2010; 467: 1109 ‐ 1113. | |
dc.identifier.citedreference | Gerlinger M, Horswell S, Larkin J, et al. Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing. Nat Genet. 2014; 46: 225 ‐ 233. | |
dc.identifier.citedreference | Chaturvedi AK, Anderson WF, Lortet‐Tieulent J, et al. Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Oncol. 2013; 31: 4550 ‐ 4559. | |
dc.identifier.citedreference | Strome SE, Savva A, Brissett AE, et al. Squamous cell carcinoma of the tonsils: a molecular analysis of HPV associations. Clin Cancer Res. 2002; 8: 1093 ‐ 1100. | |
dc.identifier.citedreference | Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010; 363: 24 ‐ 35. | |
dc.identifier.citedreference | D’Cruz AK, Vaish R, Kapre N, et al. Elective versus therapeutic neck dissection in node‐negative oral cancer. N Engl J Med. 2015; 373: 521 ‐ 529. | |
dc.identifier.citedreference | Mroz EA, Tward AD, Hammon RJ, Ren Y, Rocco JW. Intra‐tumor genetic heterogeneity and mortality in head and neck cancer: analysis of data from the Cancer Genome Atlas. PLoS Med. 2015; 12: e1001786. | |
dc.identifier.citedreference | Rocco JW. Mutant allele tumor heterogeneity (MATH) and head and neck squamous cell carcinoma. Head Neck Pathol. 2015; 9: 1 ‐ 5. | |
dc.identifier.citedreference | Mroz EA, Rocco JW. Intra‐tumor heterogeneity in head and neck cancer and its clinical implications. World J Otorhinolaryngol Head Neck Surg. 2016; 2: 60 ‐ 67. | |
dc.identifier.citedreference | Snyder A, Makarov V, Merghoub T, et al. Genetic basis for clinical response to CTLA‐4 blockade in melanoma. N Engl J Med. 2014; 371: 2189 ‐ 2199. | |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.